Showing results (271-280 of 284) with videos related to
Sort By:
Pageof 29
Plos One|July 14, 2010
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensisMichael A Apicella, Deborah M B Post, Andrew C Fowler, et al.Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.Plos One|February 9, 2026
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)A M de Jong, A T J van der Boog, C C B Post, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.Maturitas|December 6, 2025
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancerFamke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, et al.Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.Pageof 29